TU-100 has been shown to decrease intestinal inflammation in models of experimental colitis, including the trinitrobenzene sulfonic acid-induced colitis in the mouse and the adoptive transfer model of CD4+ CD45RBhigh cells in the SCID knockout mouse [7], [10]. Here, CD4 is linked to colitis.